Introduction
Culturing mammary epithelial cells on a reconstituted lamininrich extracellular matrix (ECM) (Engelbreth-Holm-Swarm (EHS) tumour derived matrix) generates 3D-cell assemblies that mature to form acini: spherical mono-layers of cells that enclose a central lumen. Acinus formation in this context requires firstly, cell polarisation and exit from the cell cycle of the outer mono-layer of cells in intimate contact with the ECM, and secondly, lumen clearance which occurs, at least in part, by an apoptotic mechanism (reviewed epithelial junctional complexes: tight junctions, adherens junctions and desmosomes (O'Brien et al., 2002; Underwood et al., 2006) . Acinus formation also requires the cultures to be supplemented with a growth factor (EGF and/or bovine foetal serum), insulin or IGF-1 and hydrocortisone (Murtagh et al., 2004) . The growth factor will stimulate that number of rounds of cell replication necessary to allow acinus formation initiate where, for instance, single MCF10A cells are used as starting material (eg. (Debnath et al., 2002) ) or a limited number of rounds of replication where dispersed primary murine mammary epithelial cells rapidly associate to initiate acinus formation. Insulin or IGF-1 support cell survival (Green and Streuli, 2004; Marshman and Streuli, 2002) . Murtagh et al. , (Murtagh et al., 2004) showed that the glucocorticoid, hydrocortisone, causes mitogen-activated protein (MAP) kinase, JNK, activation through a novel Brca1-dependent signalling cascade and that JNK activity was essential for acinus formation. It was concluded that JNK probably acts, at least in part, though c-Jun to sustain expression of adhesion molecule gene expression (Murtagh et al., 2004) .
Acinus formation has proved to be an excellent model system in which to study normal mammary epithelial cell behaviour and with which to elucidate functional differences between normal and transformed or oncogene challenged mammary epithelial cells. For instance, Weaver et al., (Weaver et al., 1997) established that the tumorigenic T-42 mammary epithelial cells fail to organise as acini in culture because of a hyper-activated b1-integrin-EGFR-ERK MAP kinase axis and would revert to behave like their related 'normal' S-1 cells (which form acini in culture) if b1-integrin or EGFR function was inhibited. Importantly, this behaviour was only observed in 3D cultures; no reciprocal down-regulation occurred when neutralizing antibodies were added to T4-2 cells cultured as mono-layers (Wang et al., 2002; Wang et al., 1998; Weaver et al., 1997) .
The complex nature of genetic alterations in transformed cells makes the identification of individual events responsible for functional alterations observed difficult. Thus, 3D culture of normal mammary epithelial cells has been used to assess the biological effects of the activation of particular oncogenes. For example, over-expressing activated ErbB2 receptor in MCF10A mammary epithelial cells, Muthuswamy et al., (Muthuswamy et al., 2001) could document a failure of lumen clearance and the failure of associated luminal cell apoptosis and so, aberrant acinus maturation. That this required a combined triggering of sustained proliferation and an anti-apoptotic/pro-survival effect was clear from the failure of over-expression of either cyclin D1 or Bcl2 alone to achieve the same effect. Again the effects of active ErbB2 over-expression were associated with sustained activation of the core intracellular signalling cascades: the MEK-ERK and PI-3-kinase signalling pathways (Debnath et al., 2002; Muthuswamy et al., 2001) .
The ability of EGFR to induce oncogenic transformation of normal human MECs is much decreased compared to ErbB2, inferring a role for cooperating oncogenes (Di Fiore et al., 1990; Neve et al., 2001; Yarden and Sliwkowski, 2001) . A 2007 study showed that cooverexpression of EGFR and c-Src (in two distinct non tumorigenic human MECs, 16A5 and MCF10A cells) initiates an oncogenic signal which generates hyper-proliferative 3D acini defined by a loss of polarity (Dimri et al., 2007) . Co-overexpression of EGFR and c-Src leads to an invasive phenotype in normal human MECs (migration of MECs in response to EGF is increased upon c-Src overexpression) and anchorage-independent growth is enhanced in these conditions. It is of note that BRCA1 mutant and basal-like phenotypes are highly aggressive subtypes of breast cancer and are characterised by overexpression of EGFR (Ansquer et al., 2005; Hu et al., 2006; Livasy et al., 2006) .
While 'normal' and 'transformed' mammary epithelial cells in 3D-culture display distinct phenotypes with the former generating acini and the latter disordered 3D assemblies, some display distinct and useful plasticity that allows rescue or reversion of phenotype. The response of primary mammary epithelial cells to the induction and deinduction of oncogenes has been assessed in 3D culture using mammary cells derived from normal virgin mice and from tritransgenic mice (in which Kras and MYC are conditionally regulated by doxycycline (TetO-MYC;TetO-Kras
G12D
;MMTV-rtTA)) (Jechlinger, 2009) . The lack of oncogenic signals leads to the rapid formation of hollow, polarised acini. Induction of Kras G12D and MYC generates enlarged, solid and unpolarised cell assemblies however, these solid spheres regress to a repolarised outer layer of viable cells after oncogene deinduction; where lumen clearance has occurred by a caspase 3 apoptotic mechanism and mitochondrial polarity is lost. Cells that tolerate doxycycline withdrawal are thought to represent a population of progenitor-like cells as they retain the ability to respond to further oncogene induction and repopulate the mammary fat pad and reseed cultures at an enhanced rate (Jechlinger, 2009) . Studies with human breast cells highlight that primary cancers display enhanced p21-activated kinase 1 (PAK1) activity, thought to correlate with increased cyclin D1 expression (Balasenthil et al., 2004) . In three-dimensional (3D) overlay cultures, pre-malignant progression of MCF10 breast epithelial cell lines has been shown to implicate PAK1 and over-expression of a PAK1 dominant-negative leads to both decreased invasion, proliferation and pericellular proteolysis of collagen IV (Li et al., 2008) . MCF10AneoT, MCF10. AT1 and MCF10.DCIS cells display a range of hyperplastic and dysplastic phenotypes including abnormal lumena and spheroid clustering. Lumen formation is promoted upon over-expression of DN-PAK1 which is considered a partial reversion of the premalignant phenotype (Li et al., 2008) . These findings are supported by previous reports of suppressed invasiveness and motility in MCF7 and MDA-MB-435 breast cancer cells upon over expression of a dominant negative PAK1 (K299R) (Adam et al., 1998; Adam et al., 2000; Vadlamudi et al., 2000) .
Wang et al., (Wang et al., 1998) showed that transformed T-42 cells would revert to generating acini if cultured in the presence of a MEK-ERK pathway inhibitor. These authors extended this work to show that the combined inhibition of multiple signaling pathways was able to restore more normal acinus forming capability to a range of breast cancer cell lines in 3D cultures (Wang et al., 2002) . A parallel approach was successful with MCF10A cells in which autocrine activation of colony-stimulating factor receptor In monolayer culture, increased nucleus-to-nucleus distance, transition to mesenchymal phenotype, and induction of focal adhesions at wound borders.
Markers of EMT expressed in 3-D structures exposed to SP600125
[see Supplemental Fig 
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A (CSF-1R) had been induced. This resulted in a severe disruption of MCF10A acinus architecture where excessive proliferation and aberrant survival was accompanied by progressive disruption of cell-cell adhesion in these structures and culminated in the release of individual cells into the surrounding matrix (Wrobel et al., 2004) . The adhesive defect is dependent upon the ability of CSF-1R to chronically activate Src family kinases and these CSFR-mediated effects could be blocked using a Src inhibitor. Thus, the disruptive effects of cell transformation or inappropriate receptor tyrosine kinase activation or oncogene expression on acinus formation is transmitted through key associated intracellular signalling pathways. The ERK MAP and PI-3 kinase pathways have, in particular, been implicated as downstream transducers in this context and their inhibition can protect from the deleterious effects on acinus formation (Debnath et al., 2003b , Janda et al., 2002 Pinkas and Leder, 2002; Reginato and Muthuswamy, 2006; Wang et al., 2002) .
Here we have further investigated the requirement for JNK activity during acinus formation by primary mammary epithelial cells. Inhibition of JNK (using SP600125) or JNK1 'knockdown' (using small interfering RNA (siRNA)) resulted in the generation of cell assemblies that did not polarise nor exit the cell cycle, that failed to undergo apoptosis (paralleled by ERK-dependent BimEL phosphorylation), that expressed markers of epithelialmesenchymal transition (EMT) and had sustained, high levels of phospho-ERK. These effects could be blocked (or reversed) by generating the spheres in the presence of a MEK-ERK signalling inhibitor. Interestingly, during normal acinus formation, ERK-specific phosphatase (MKP-2 and -3) expression was induced and this may also support the restriction of ERK pathway signalling required for normal acinus formation. JNK inhibition with SP600125 also blocked acinus formation by MCF10A cells; spheroids of non-polarised cells formed and lumen clearance failed. Interestingly, over-expression of dominant-negative JNK1 in MCF10A cells led to the formation of large 'multi-acinar spheres' whose formation is probably driven by excessive luminal cell proliferation and cell survival rather than compromised cell polarisation. This was a milder effect than that induced by the chemical JNK inhibitor. Lastly, by studying the behaviour of MCF10A cells immediately after seeding (30min -6h) in laminin-rich ECM under conditions that support acinus formation: we could pin-point very early influences of JNK on organisation of mammary epithelial cells in 3D. Inhibition of JNK activity or expression of dominant negative JNK1 allowed cell engagement to matrix (and b1-integrin activation), but blocked cell polarisation and so, all subsequent 'behaviours' (ie. Motility, clustering etc.). And, while integrin activation occurred, phosphorylation on tyrosine of paxillin, Fak and Src (reflective to recruitment to integrin and initiation of integrin 'outside-in' signalling) was significantly damped by JNK inhibition. Our results emphasise the multi-phase dependency of the organisation of mammary epithelial cells in 3D on JNK activity and suggest a 'permissive' support of ECM-integrin 'outside-in' 
Fig. 3. JNK inhibition suppresses focal adhesion-associated protein phosphorylation but induces sustained phosphorylation of EGF receptor and ERK in forming acinus. (A) SP600125 treatment causes loss of polarised baso-lateral localisation of active-b1-integrin (green) and apical localisation of F-actin (red) in forming primary mammary epithelial cell acini. (B) Western analysis shows loss of phosphorylation/activation of focal adhesion associated proteins, FAK (pY397), paxillin (pY118) and Src (pY416) in acini forming in the presence of SP600125. (C) Western analysis shows increased phosphorylation/auto activation of EGFR (p-Y-1173) and phosphorylation of ERK in SP600125 treated acini. In addition, SP600125 treatment caused a 'band-shift' in BimEL and phosphorylation of Bim on ERK targeted ser-65. Expression of the JNK1 specific shRNA in cells forming acini also induced increased ERK phosphorylation.
active β1-integrin SP600125 N dapI merge 48h F-actin
Results

Inhibition of JNK activity impaired cell polarisation and lumen clearance during acinus formation
We have previously shown that JNK is phosphorylated / activated during acinus formation by primary mammary epithelial cells supported by a laminin-rich ECM (see also Supplemental Fig. S1 ). In addition, we showed that omission of glucocorticoids, an essential component of the culture medium, both impaired acinus formation and stopped JNK activation (Murtagh et al., 2004) . Here we show that SP600125, the small molecular weight JNK inhibitor, blocks lumen clearance as judged by EtBr staining for dead cells and loss of the apoptosis marker, cleaved caspase 3 (Fig. 1A ) and so impairs acinus formation by primary mammary epithelial cells. In addition, SP600125 treatment stopped the cell polarisation and proliferation restriction (and suppression of cyclinD1 expression) that accompany acinus formation ( Fig. 1 A,B) . That JNK activity was essential for acinus formation was validated by knocking down JNK1 using a specific small hairpin RNA (shRNA) delivered from a recombinant lentivirus: JNK knockdown again blocked both lumen clearance and cell polarisation (the latter judged by apical localisation of F-actin) ( Fig 1C) .
These experiments reiterated the requirement for JNK signalling in driving cell polarisation during acinus formation (see also (Whyte et al., 2010) ). A likely target of this (glucocorticoid) -JNK signalling axis is maintenance of expression of adhesion proteins (Murtagh et al., 2004) , which play a role in establishing and maintaining the polarised state of organised epithelial cell aggregates. This was further investigated.
Disruption of acinus formation by JNK inhibition triggers expression of markers of EMT
During acinus formation, JNK inhibition with SP600125 both inhibited cell polarisation (above) and caused mis-localisation and reduced cell levels of tight junction protein, ZO-1 (Fig 2A) . This was paralleled by a reduction in ZO-1 mRNA levels (Murtagh et al., 2004) , reduced occupation of an AP-1 binding element in the ZO-1 gene proximal promoter by cJun and cFos and, in contrast, increased occupancy of E-boxes by snail in the same promoter (Fig 2A, bottom panel) . These findings suggested that the loss of JNK signalling in these 3D assemblies was causing the cells to adopt a more mesenchymal phenotype: We could show that these cells expressed a comprehensive range of markers of EMT, once JNK was inhibited. We saw: that 1. occludin expression was reduced and that it was mis-localised; that occupation of Eboxes in the occludin promoter was induced by Snail1 while cFos/ cJun occupation of AP1 elements was lost; 2. Elevated fibronectin expression; 3. Depressed E-cadherin and increased N-cadherin expression; 4. Increased MMP-2 and -9 expression; and increased Snail1 occupation of E-boxes in these MMP promoters; and; 5. In monolayer culture, increased nucleus-to-nucleus distance, a transition to mesenchymal phenotype, and induction of focal adhesions at wound borders (summarised in Fig 2B, see data in, Fig.  S2A -E). Thus inhibition of JNK during acinus formation leads to the expression of a comprehensive range of markers of EMT. We could also show that SP600125 triggered expression of the EMT/ mesenchymal marker, vimentin so also did knock down of JNK1 using the specific shRNA (Fig. 2C ).
Inhibiting ERK activation protects from the effects of JNK inhibition on acinus formation
Acinus formation by primary mammary epithelial cells saw the expression of activated b1-integrin at the baso-lateral surface of those cells in immediate contact with the ECM (Fig. 3A) . In addition western analysis showed the parallel phosphorylation/activation of intracellular proteins normally recruited to such activated integrins (FAK, paxillin and Src). Inhibition of JNK with SP600125 disturbed the localization of the b1 integrin and suppressed the phosphorylation of the integrin associated proteins (Fig. 3A) . In contrast, inhibition or knockdown of JNK during acinus formation led to persistent increases in the phosphorylation/auto-activation acinus formation. We show that inhibition of ERK activation with the kinase inhibitor, PD98059, was sufficient to block the impairment of lumen clearance caused by JNK inhibition, as judged by vital dye staining (calceinAM and EtBr) and luminal cell apoptosis, detected by cleaved caspase3 staining (Fig. 4A ). Fig. S3 shows that PD98059 not only reverses the effect of SP600125 but also gives rise to small acini. In addition, inhibition of ERK activation permitted normal cell polarisation (F-actin and E-cadherin localisation, Fig. 4B ) and normal suppression of cell proliferation (BrdU incorporation, Fig. 4C ) and suppression of ERK-dependent Bim phosphorylation and activation of Src (Fig. 4D) and, finally, suppression of vimentin expression (Fig. 4E) . Thus, inhibition of ERK activation triggered by JNK inhibition was sufficient to protect from the effects of JNK inhibition during acinus formation. The EGFR inhibitor (AG1478) was also effective in protecting acinus formation by the primary mammary epithelial cells from the effects of JNK inhibition (data not shown).
Likewise, inhibition of ERK activation was sufficient to reverse the effects of JNK inhibition after the latter was initiated 17h before addition of the MEK inhibitor, PD98059. Again inhibition of ERK activation was sufficient to reverse all aspects of acinus formation impaired by JNK inhibition (ie cell polarisation, lumen clearance and luminal cell apoptosis, inhibition of Bim activity, suppression of expression of markers of EMT and reactivation of Src) (Fig. S4 a-f ) .
It is clear, therefore, that acinus formation will only execute successfully if EGFR-ERK signalling is restricted. This is primarily achieved by restricting EGFR activity but dephosphorylation/inactivation of phospho-ERK by ERK-directed phosphatases (MKPs) could also contribute. The two principal ERK-directed MKPs are MKP-2 and MKP-3 (Camps et al., 2000; Farooq and Zhou, 2004; Karlsson et al., 2004; Keyse, 2000; Zhang et al., 2002) . Levels of MKP-2 and -3 were high in whole cell extracts of normal acini, of the EGF receptor and of its downstream modulator ERK (Fig. 3C ). This would suggest that the impairment of acinus formation, by inhibiting JNK, arises due to a shift in balance between integrin-JNK signalling and EGFR-ERK signalling, with the latter now dominant. We therefore investigated whether inhibition of ERK activation was sufficient to protect from or reverse the effect of inhibition of JNK signalling during B A C D and low in the presence of the JNK inhibitor (Fig. 5A) . Levels of the nuclear localised MKP-2 rose in nuclear extracts during normal acinus formation but not on JNK inhibition (Fig. 5B ). MKP-3 levels measured in whole cell extracts showed a similar profile (Fig. 5B ).
There was a striking correlation between rising MKP-2 and -3 levels and falling p-ERK levels as acini formed (Fig. 5C ). Failure of acinus formation and sustained high p-ERK levels in cultures treated with SP600125 were associated with constitutively low levels of MKP-2,-3. Thus, MKP-2 and -3 may contribute to the efficient constraining of active ERK levels during acinus formation.
There is an interesting contrast between the expression of MKP-2 and -3 and the phospho-JNK-directed phosphatase MKP-1 during acinus formation: MKP-1 is expressed at a high level during normal acinus formation, when the levels of its active target are high (in contrast to the ERK-directed MKPs) (Fig. 5 C,D) . Its expression is lost when JNK is inhibited. In a number of biological models (Llense and Martin-Blanco, 2008) active JNK induces MKP1 expression as part of an auto-regulatory negative feedback loop.
The requirement of JNK for cell polarisation, and lumen clearance during acinus formation are temporally separable events
Cell polarisation precedes lumen clearance during acinus formation. It was of interest to examine the dependency of both events on JNK. We observed that addition of the JNK inhibitor, SP600125, to the primary mammary epithelial cells at time of plating inhibited both events. However, if the JNK inhibitor was added to the forming acini 6h or more after cell seeding, cell polarisation was unaffected, while lumen clearance was still inhibited (Fig. 6A,  b) . Thus, the requirement of JNK for cell polarisation and lumen clearance during acinus formation are temporally separable. In addition, we investigated the ability of ERK inhibition to separately protect these two events from JNK inhibition. Interestingly, we found that cell polarisation was fully protected by ERK inhibition while lumen clearance was significantly less so (Fig. 6B) . At this time the reason for this difference in sensitivity to ERK inhibition under these conditions is not understood
Inhibition of JNK also impairs acinus formation by MCF10A cells
In order to establish JNK signalling as a general requirement for mammary epithelial cell acinus formation, we investigated the effects of JNK inhibition on acinus formation by the human mammary epithelial cell line, MCF10A. We observed MCF acini on day 8 of culture. At this time, 2 distinct sub-populations of cells are apparent: polarised cells in contact with the matrix, and, disorganised luminal cells, programmed to die (see Fig. S5a ). In MCF10A 3D cultures, inhibition of JNK with SP600125 impairs acinus formation and generates spheroids of surviving / proliferating, unpolarised cells with elevated levels of activated ERK (Fig. 7 A-C) reminiscent of treating the MCF10A cultures with the standard inducer of EMT, TGF-b (Fig. S5 b-d) ; or of treating cultures of primary mammary epithelial cells with the same inhibitor (compare Figs. 7 A,B and 1  A,B) . It should be noted that to observe this effect the SP600125 must be added at the lower concentration of 20 mM, and > 3d after seeding, earlier addition results in no spheroid development.
Expression of a dominant negative (activation deficient) JNK1 in MCF10A cells subverts acinus formation
Using the MCF10A cells we could investigate the effect of overexpression of a dominant-negative, activation-deficient JNK mutant protein (Fig. 8A ) on acinus formation. Overexpression was achieved by infecting the cells with a recombinant lentivirus carrying the mutant JNK gene. Empty-vector infected cells and cells overexpressing wild-type JNK, were used for control purposes. The viruses also delivered GFP and green fluorescence monitored infection efficiency. It was clear from forming acini at day 4 that adequate infection had been achieved and spheroid formation was proceeding (Fig. 8 A,B) . However, by day 8 phase contrast microscopy showed that the JNK DN infected spheres were now large and multi acinar (Fig. 8A) . Immunefluorescence confocal microscopy analysis showed that the JNK-DN expressing acini were indeed large and multi acinar, while normal acini were generated by the (Fig. 8B ). In the multi-acinar spheres cell polarisation (as judged by E-cadherin and GM130 distribution) seemed normal, as did rates of luminal cell apoptosis (Fig. 8C) . However, luminal cell proliferation rates were high (at d8) and luminal cell survival may have been enhanced (Fig. 8D) . By western blot analysis, the activation of dominant negative JNK was reflected by the expected reduction in JNK-dependent cjun activation/phosphorylation and corresponding reduction in levels of activated Src and Paxillin (Fig. 8E) . Thus, acinus formation by MCF10A cells does indeed require JNK. However, the potency of effect of using the chemical inhibitor and dominant negative protein may differ with the latter not affecting cell polarisation, but more influencing the regulation of cell proliferation.
(A) Confocal immune fluorescence analysis: addition of SP600125 to forming acini 6 h after cell seeding impaired polarised localisation of b-catenin (green) and F-actin (red) and lumen clearance (note luminal DAPI staining); but addition of SP600125 17 h after cell seeding impaired lumen clearance but not cell polarisation. (B) Quantitative analysis of effects of SP600125 added to cells forming acini at time of cell seeding or 6 h and 17 h thereafter on lumen clearance and cell polarisation. Multiple analyses of fields of acini were analysed by phase contrast microscopy. The ability of PD98059 to reverse impairment of cell polarisation and lumen clearance by SP600125 treatment was also analysed.
JNK activity is required to support immediate responses of MCF10A mammary epithelial cells to engaging ECM in 3D cultures
In the period immediately after plating MCF10A cells in EHS-ECM, under conditions that support acinus formation, we can detect a series of 'key events': 1. Engagement of the cells with the matrix (reflected by stable 'suspension' of cells within matrix and significant 'active-b1-integrin' staining, from as early as 30min after cell plating); 2. Cell polarisation; 3. Movement of cells towards nascent clusters (reflected by mesenchymal shape and extension of processes to clusters): and 4. Formation of clusters of cells and expression of epithelial markers (ie. Adhesion molecules at cell-cell interfaces).
Inhibition of JNK with SP600125 had no immediate effect on cell engagement to matrix, as reflected by numbers of cells stably suspended in matrix (DAPI staining, 30min -2h (Fig . 9A) ) and extent of active b1-integrin activation (Fig. 9B) . However, inhibition of JNK activity clearly blocked 'early' cell polarisation, and downstream cell behaviours (motility, and formation of clusters). Thus, at 4h JNK inhibited cultures are a collection of single un-polarised cells 'frozen' / suspended within the matrix. In contrast, normal cultures are an active amalgam of polarised cells moving into clusters (and adopting a more epithelial phenotype once settled within a cluster (Fig. 9C) . At a molecular level, JNK inhibition seemed to impair the efficiency of phosphorylation / activation of a range of key integrin-associated proteins (paxillin, FAK and Src) (Fig. 9 D-F) . Expression of the dominant negative JNK1 in MCF10A cells had a similar effect on cell behaviour in the period early after seeding the cells in the laminin-rich ECM: JNK-DN expressing cells were predominantly single and unpolarised (eg. Fig. 9G, bottom panel) . In contrast, empty vector and JNK wt infected cells were predominantly in clusters. Again, phosphorylation/activation of Src, FAK and paxillin was under-powered in the presence of the dominant negative (Fig. 9 G-I) . Note that the phosphorylation of the integrinassociated proteins was most intense in the cells over-expressing JNK wt. We conclude that JNK is required to support molecular events downstream of integrin activation in the immediate aftermath of matrix engagement at the initiation of MCF10A cell participation in acinus formation.
Overall, our results emphasise the multi-phase dependency of the organisation of mammary epithelial cells in 3D on JNK activity and suggests a 'permissive' support of ECM-integrin 'outside-in' signalling and a 'damping' of growth factor ERK signalling as its two key cell physiological targets.
Discussion
We have observed a requirement for JNK activity in supporting the organisation of mammary epithelial cells in three dimensions, most particularly in the formation of acini. In these studies we have In order to modulate JNK activity in these culture cells, we have used an established specific small molecular weight JNK inhibitor (SP600125), we have knocked down JNK1 using lentiviral delivery of a JNK-specific shRNA, and, finally, we have overexpressed an activation-deficient dominant negative JNK mutant. These different and independent approaches have added validity to our experimental observations. The dispersed primary mouse mammary cells formed mature acini when cultured on the laminin rich ECM in the presence of insulin, EGF and hydrocortisone. Addition of the small molecular weight JNK inhibitor impaired cell polarisation, withdrawal from the cell cycle and lumen clearance, the necessary steps in acinus formation. The JNK inhibited cells formed loosely aggregated spheroids and expressed a range of markers of EMT. Expression of the JNK1 specific shRNA had a similar effect. This validated the requirement for JNK for acinus formation in this model system. Of particular note was that cell proliferation and EGFR-ERK signalling persisted once JNK was inhibited. This led us to show that inhibition of ERK activation was sufficient to protect acinus formation from impairment by JNK inhibition. EGFR inhibition was also sufficient to provide this protection. These data suggest that a primary requirement for acinus formation is the down regulation of EGFR-ERK signalling and associated restriction of cell proliferation. This requirement has also been described for the formation of MCF10A cell acini (Weaver et al., 1997) . However, this is the first time that the requirement for JNK activity to support this proliferation restriction, has been reported.
(A) Addition of SP600125 to MCF10A cells 3 days after seeding impairs the initiation of lumen clearance (at day 8, as judged by DAPI staining of nuclei) and cell polarisation (as judged by b-catenin distribution). The upper panels show a field of acini, the lower show a single representative acinus. (B) Treatment of MCF10A cells forming acini with SP600125 (bottom panel) impairs the polarised distribution of the golgi marker, GM130 (green). (C) Western analysis: failure of acinus formation by MCF10A cells in the presence of SP600125 (added on day 4) is paralleled by persistent ERK phosphorylation activation.
infected with recombinant lentiviruses, carrying empty vector (pWPI), wild type JNK1 (pWPI-JNK1-WT) and the dominant-negative (pWPI-JNK1-DN) at day 4 and day 8 after cell seeding. Note the comprehensive GFP staining (green), reflecting successful infection. Also clear is the generation of multi-acinar spheres in the pWPI-JNK1-DN infected cells. (B) Confocal immunefluoresence microscopy analysis shows the formation of multi-acinar spheres by MCF10A cells expressing the JNK1-DN protein (dapi, blue; GFP, green). (C) Expression of the JNK1-DN causes formation of multi-acinar spheres at day 8, but with little disturbance of polarised GM130 and E-cadherin localisation. In the case of the GM130 analysis, fields of, and individual acini are shown. Expression of empty vector and JNK1-WT had no effect on acinus development. (D) Expression of the JNK1-DN did not affect levels of luminal apoptosis (cleaved caspase3 staining (red)) but did increase levels of luminal cell proliferation (Ki67 staining (red)) at day 8 of acinus formation. (E)
We also provide evidence that the requirement for JNK activity for acinus formation can be separated into two temporally independent events. We show that, while addition of SP600125 to primary cultures at time of seeding inhibits both cell polarisation and lumen clearance, addition of the JNK inhibitor later (after 6h or more) inhibits only lumen clearance. Thus, there may be two cellular targets for JNK in this context. The first, which supports establishment of cell polarisation, probably lies upstream of PKCζ activation on a signalling path downstream of activated b1 integrin (Whyte et al., 2010) . The later target, which supports lumen clearance, is likely to centre on rac1 activation (Keely et al., 1997; Muthuswamy et al., 2001) .
Using MCF10A cells, it was possible for us to show in an independent system of acinus formation, that JNK activity was again necessary to support this organisation of mammary epithelial cells in 3D. However, the MCF10A cells proved to be more sensitive to the chemical inhibitor. In particular, it needed to be added at least 3 days after culture was initiated. Of note is the fact that we have routinely observed these acini at day 8 of culture, when two separate populations of cells are robustly apparent in the acini. Firstly, polarised cells in intimate contact with the ECM, and secondly, a separate disordered population of luminal cells (see Fig. S5a ). The JNK inhibitor impaired acinus formation by the MCF10A cells in a similar fashion to its effect on the primary acinar cultures. It led to failure of cell polarisation, failure of lumen clearance and the persistent activation of ERK (Fig. 7 A-C) . It led to the generation of spheroids of loosely associated disordered cells. With the MCF10A cells, it was also possible to inhibit normal JNK function by the overexpression if an activation-deficient JNK mutant protein.
Again, down regulation of cellular JNK drive by this method, affected acinus formation. Control expression of the empty delivery vector, or wild type JNK1, had no qualitative effect on acinus formation. Expression of the dominant negative generated multi -acinar spheres, a phenotype that has been widely reported. For instance, overexpression of active ErbB2 (Muthuswamy et al., 2001) or overexpression of a kinase-dead PKCζ (Whyte et al., 2010) leads to such an outcome. In these multi-acinar spheres, cell polarisation seems unaffected and the impairment seems to arise due to excessive proliferation of the luminal cells and/or their persistent survival. It would seem therefore, that expression of the dominant negative has had a milder effect on acinus formation than had the small molecular weight inhibitor, SP600125.
The sensitivity of the MCF10A cells to JNK inhibition at early times of culture led us to investigate a possible requirement for JNK activity in the initial interactions between cells and ECM in these 3D cultures. We observed cell behaviour in a window from 30 min to 6h after cell seeding. We could define a series of early behaviours: the cells engaged the matrix, they polarised, they moved into clusters and, finally, within the clusters they exhibited epithelial like behaviours. Inhibition of JNK using SP600125, or by overexpressing the dominant negative protein, arrested the development of this pattern of behaviours at an early stage. It did not have an effect on engagement of the cells with the matrix, but it robustly inhibited cell polarisation and, therefore, its downstream consequences, motility, cluster formation and epithelisation. At a molecular level, it did not seem to affect b1 integrin activation, but seemed to dampen phosphorylation/activation of integrin associated intracellular signalling proteins i.e. FAK, paxillin and Src. These studies point to a requirement for JNK in supporting the efficient generation of signal from integrin that is necessary to drive the organisation of mammary epithelial cells in three dimensions.
In summary, we have comprehensively analysed the requirement for the MAP kinase, JNK in supporting the organisation of mammary epithelial cells in three-dimensional cell cultures, particularly, its effect on acinus formation. In addition, we report for the first time on the use of very short-term 3D MCF10A cultures, and note its significant suitability for mechanistic studies.
Materials and Methods
Cell culture
Mouse mammary epithelial cells were harvested from mid-to latepregnant CD-1 mice and cultured as described previously (Furlong et al., 1996; Murtagh et al., 2004) . Cells were seeded on tissue culture dishes coated with concentrated, growth factor depleted, EHS ECM (Matrigel ® ; BD Biosciences; 1.74 mg protein/6 cm 2 plate) at a density of 2.4 X 10 6 cells/ ml and cultured with 5 ng/ml epidermal growth factor (Promega), 5 mg/ml insulin (Sigma-Aldrich), 1mg/ml hydrocortisone (Sigma-Aldrich), and 50 mg/ ml gentamycin (Sigma-Aldrich) in F12 medium (Life Technologies, Inc.). These cells were harvested after 1-4 d in culture. Acini were recovered by scraping and were pelleted by centrifugation. The cell pellets were snap frozen and stored at -80°C before RNA or protein extract preparation. 50 mM SP600125 (Calbiochem), 10 mM PD98059 (Calbiochem) and 10 mM AG1478 (Calbiochem) were added to cells either at time of plating or after 17 h. For 2-D mono-layer studies cells were seeded onto 2 chambered plastic slides coated with diluted EHS matrix (1:5, Matrigel: Ham's F-12) using identical culture conditions. Cells were fixed and stained at 48 h.
MCF10A cells were cultured exactly as described previously (Whyte et al., 2010) and as outlined in (Debnath et al., 2003a) . Epidermal growth factor (EGF, 20ng/ml (Sigma)) was added after each cell splitting procedure (unless stated otherwise). 20mM SP600125 was added on day 3 to MCF10A cells, and cells were harvested/fixed on days 4 and day 8, or day 10 for transduction experiments. For short term 3D culture of MCF10A cells, the cells were counted and seeded (1x10 4 cells/ml) on EHS-ECM pre-coated glass chamber slides in medium supplemented with 2% Matrgel® and 20ng/ ml EGF. Inhibitors were added to cells (SP600125 (20 mM) (Calbiochem)) at the time of plating, unless otherwise stated. Cells were harvested and fixed at 30 min, 2h, and 4h after seeding.
Cell extract preparation and Western blot analysis
Whole cell extracts were prepared by re-suspending pelleted cells in 50-100 ml of extraction buffer (Furlong et al., 1996; Murtagh et al., 2004) . The samples were kept on ice for 30 min before centrifugation at 14,000 rpm at 4°C for 20 min. The supernatant constituted the whole cell extract.
Western blot analysis was performed as described previously (Furlong et al., 1996; Murtagh et al., 2004) . For a list of antibodies used, see Supplemental Fig. S7a(i) .
RT-PCR analysis
Cultured cells or cell assemblies were gently scraped from the plates, briefly centrifuged, washed by resuspension in PBS, centrifuged, and resuspended in TRIzol ® Reagent (Invitrogen). Reverse transcription and limited cycle PCR were performed as described previously (Murtagh et al., 2004; O'Brien et al., 2002) . Primers were designed using Primer3 software (Rozen and Skaletsky, 2000) . Primer sequences are given in Fig S7e. 
Microscopy
Acini were fixed using 2% (MCF10A) or 4% PFA (primary cells) for 20 minutes at room temperature and stained as previously outlined (Whyte et al., 2010) . Cells were incubated with primary antibodies (or phalloidin/ rhodamine (Molecular Probes)) overnight at 4°C in a humidity chamber and then incubated with FITC, Texas-red conjugated, or Alexa-Fluor 555 goat anti-mouse/rabbit (Molecular Probes) secondary antibodies in darkness for 1 hour. For a list of primary staining antibodies used, see Supplemental Fig. S7a (ii). Slides were mounted in Prolong Gold anti-fade reagent with Dapi (Molecular Probes). For analysis with vital dyes, acini were incubated with 10 mg/ml EtBr and 10 mM Calcein AM (Molecular Probes) for 10 min at 37°C. For BrdU incorporation, BrdU was added to forming acini for 24 h periods (0-24 h or 24-48 h). After incubation, cells were fixed and incubated with methanol at -20°C for 30 min. Cells were washed with ice cold PBS and treated with 2N HCl for 30 min with rotation. Excess HCl was removed and remaining HCl was neutralised by incubation of the cells with 0.1M sodium borate (Borax, Sigma) for 5 min with rotation. Cells were washed with PBS for 2 min and permeablised with 0.5% Triton X-1000 for 10 min. FITC conjugated monoclonal mouse anti-BrdU stock solution (BD Pharmingen) was added to the sample for 30 min before visualisation. Images were captured using a Bio-Rad MRC 1024 or a Carl Zeiss Laser Scanning LSM 510 Meta Confocal microscope.
Chromatin immuneprecipitation (ChIP) analysis
ChIP analysis was performed using a ChIP assay kit purchased from Upstate Biotechnology as we have previously described (Murtagh et al., 2004) . Acini were cross-linked on the cell culture plates by adding 135 ml 37% formaldehyde to the 5.0 ml medium and incubating at 37°C for 10 min. After glycine addition and washing with cold PBS, the cell assemblies were scraped from the plates in PBS into a 1.5 ml centrifuge tube and treated with SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris, pH 8.1 and 1 mg/ml each of aprotinin, leupeptin, and pepstatin A) on ice for 10 min. Samples were sonicated on ice (setting 15, 3 X 10-s pulses; Ultrasonics sonicator) to reduce DNA length to 200-1,000 bp and centrifuged for 10 min at 14,000 rpm at 4°C. The supernatant was diluted 10-fold in ChIP buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7mM Tris, pH 8.1, 167 mM NaCl, and 1 mg/ml each of aprotinin, leupeptin, and pepstatin A) and the chromatin solution (1.0 ml) and 5 ml antibody, anti-c-Jun (Cell Signaling Technology), anti-c-Fos (Oncogene) or anti-snail (Santa Cruz Biotechnology Inc.)) or no antibody (negative control) were incubated overnight at 4°C with rotation. Before immunoprecipitation, 50 ml of chromatin solution was saved (input chromatin) and this was processed with the eluted immunoprecipitates beginning at the cross-link reversal step. The immunocomplexes were collected by adding 60 ml of salmon sperm DNA/protein A-agarose and rotating for 1 h at 4°C. The beads were recovered by brief centrifugation, washed with low salt complex wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, 150 mM NaCl), high salt complex wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mMTris-HCl, pH 8.1, 500 mM NaCl), LiCl immunocomplex buffer (0.25% LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA, 1mM EDTA, 10 mM Tris-HCl, pH 8.1) and TE, pH 8.0, with brief centrifugation between each wash to recover the beads. The immune complexes were eluted from the beads by the addition of 500 ml 1% SDS in 0.1 M NaHCO 3 to the bead pellet, vortexing and rotating at room temperature for 30 min. To reverse the cross-linking process, 200 mM NaCl was added to the eluates which were then incubated at 65°C for 4 h. 10 mM EDTA, 40 mM Tris-HCl, pH 6.5, and 2 ml of 10 mg/ml proteinase K was then added and incubated at 45°C for 1 h. DNA was recovered by phenol/chloroform extraction and ethanol precipitation. Promoter sequences were detected in immuneprecipitated and input DNA by PCR using specific primers. A parallel ChIP analysis for each promoter was performed using an anti-acetylated histone H3 antibody as a positive control (data not shown). Details of promoter structure, PCR strategy and PCR primer sequences are given in Fig. S7(b-e) .
small hairpin RNA transduction using recombinant lentiviruses
The following siRNA sequences targeted against mouse JNK-1 mRNA (cDNA) sequence (NM016700):
JNK1sh1: 5'-GTGGCATGTGCTGTGATCA-3'; JNK1sh2: 5'-AGCAGGGACCCATGGAAGT-3'; and JNK1sh scr: 5'-GTTTACATAAAGGTTGAGG-3') were designed using the MIT Whitehead website (http://jura.wi.mit.edu/bioc/siRNAext/). siRNA sequences were used to make shRNA cassettes) which were subsequently cloned directly into the shRNA expressing lentivector, pLVTHM, using Cla-1 / Mlu-1 restriction sites downstream of the H1 promoter. Presence of the shRNA cassette was verified by DNA sequencing. Scrambled versions of the siRNA sequences were also cloned into pLVTHM. Lentiviral particles were produced by transfecting HEK293t cells with a mix of the transfer vector (pLVTHM-JNK-shRNA), packaging vector (pCMVDR8.9) and envelope vector pMD.G (all as described in: http://tronolab.epfl.ch/ webdav/site/tronolab/shared/protocols/cloning_strategies.html). Medium containing secreted lentivirus was collected 48h post transfection and filtered through 0.45mm low protein binding filters. Lentivirus containing medium was used immediately or frozen at -80 o C. Primary mammary epithelial cells were plated on plastic dishes as a mono-layer and infected with the lentivirus-containing medium 24 h post plating. The medium was removed and replaced and the cells cultured for a further 24 h. The cells were subsequently trypsinized and replated on tissue culture plates and slides coated with Matrigel (see above). Acini formed from the infected cells were either harvested for protein analysis or fixed for immunefluorescence microscopy analysis.
MCF10A lentivirus transduction
Genes (cDNAs) to be expressed were purchased from Addgene (catalogue numbers 13798, 13846 and 12254) and cloned from pCDNA3, into pWPI. All MCF10A virus transduction protocol was carried out as previously described in (Whyte et al., 2010) . See Supplemental Fig. S6a for schematic of JNK virus constructs used in these studies. Quicktitre Lentivirus Quantitation kit (Cell Biolabs) was used to quantitate virus particles per ml (VP/ml). Addition of 2.5 x 10 9 VP or ~250 mL of virus solution per well was sufficient for ~100% infection without toxicity.
